| 1 |
Barrientez B, Nicholas SE, Whelchel A, et al. Corneal injury: clinical and molecular aspects [J]. Exp Eye Res, 2019,186:107709.
|
| 2 |
Singh R, Gupta N, Vanathi M, et al. Corneal transplantation in the modern era [J]. Indian J Med Res, 2019,150(1):7-22.
|
| 3 |
Jahanafrooz Z, Bakhshandeh B, Behnam Abdollahi S, et al. Human amniotic membrane as a multifunctional biomaterial: recent advances and applications [J]. J Biomater Appl, 2023,37(8):1341-1354.
|
| 4 |
Lacorzana J. Amniotic membrane, clinical applications and tissue engineering. Review of its ophthalmic use [J]. Arch Soc Esp Oftalmol (Engl Ed), 2020,95(1):15-23.
|
| 5 |
López Martínez JA, Rodríguez Valiente M, Fuente-Mora C, et al. Use of cryopreserved human amniotic membrane in the treatment of skin ulcers secondary to calciphylaxis[J]. Dermatol Ther, 2021, 34(2): e14769.
|
| 6 |
Li J, Qiu C, Zhang Z, et al. Subretinal transplantation of human amniotic epithelial cells in the treatment of autoimmune uveitis in rats [J]. Cell Transplant, 2018, 27(10):1504-1514.
|
| 7 |
Bai X, Liu J, Yuan W, et al. Therapeutic effect of human amniotic epithelial cells in rat models of intrauterine adhesions[J]. Cell Transplant, 2020, 29:963689720908495.
|
| 8 |
Tan B, Yuan W, Li J, et al. Therapeutic effect of human amniotic epithelial cells in murine models of hashimoto's thyroiditis and systemic lupus erythematosus[J]. Cytotherapy, 2018,20(10):1247-1258.
|
| 9 |
Leal-Marin S, Kern T, Hofmann N, et al. Human amniotic membrane: a review on tissue engineering, application, and storage[J]. J Biomed Mater Res B Appl Biomater, 2021,109(8):1198-1215.
|
| 10 |
Yang PJ, Yuan WX, Liu J, et al. Biological characterization of human amniotic epithelial cells in a serum-free system and their safety evaluation[J]. Acta Pharmacol Sin, 2018,39(8):1305-1316.
|
| 11 |
Qiu C, Ge Z, Cui W, et al. Human amniotic epithelial stem cells: a promising seed cell for clinical applications[J]. Int J Mol Sci, 2020,21(20):7730.
|
| 12 |
Zhang Q, Lai D. Application of human amniotic epithelial cells in regenerative medicine: A systematic review [J]. Stem Cell Res Ther, 2020, 11(1):439.
|
| 13 |
Liu QW, Huang QM, Wu HY, et al. Characteristics and therapeutic potential of human amnion-derived stem cells [J]. Int J Mol Sci, 2021, 22(2):970.
|
| 14 |
Banas RA, Trumpower C, Bentlejewski C, et al. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells [J]. Hum Immunol, 2008, 69(6):321-328.
|
| 15 |
McDonald C, Siatskas C, Bernard C. The emergence of amnion epithelial stem cells for the treatment of multiple sclerosis[J]. Inflammation and Regeneration, 2011, 31(3). doi: 10.2492/inflammregen.31.256.
|
| 16 |
Wassmer CH, Berishvili E. Immunomodulatory properties of amniotic membrane derivatives and their potential in regenerative medicine[J]. Curr Diab Rep, 2020,20(8):31.
|
| 17 |
Munoz-Torres JR, Martínez-González SB, Lozano-Luján AD, et al. Biological properties and surgical applications of the human amniotic membrane[J]. Front Bioeng Biotechnol, 2022,10:1067480.
|
| 18 |
Jie J, Yang J, He H, et al. Tissue remodeling after ocular surface reconstruction with denuded amniotic membrane [J]. Sci Rep, 2018, 8(1):6400.
|
| 19 |
Hu Z, Luo Y, Ni R, et al. Biological importance of human amniotic membrane in tissue engineering and regenerative medicine[J]. Mater Today Bio, 2023, 22:100790.
|
| 20 |
Walkden A. Amniotic membrane transplantation in ophthalmology: An updated perspective [J]. Clin Ophthalmol, 2020, 14:2057-2072.
|
| 21 |
Zhao X, Zuo X, Zhong J, et al. Heparin-modified amniotic membrane combined with growth factors for promoting corneal wound healing after alkali burn [J]. Front Bioeng Biotechnol, 2020, 8:599800.
|
| 22 |
Mayer WJ, Grüterich M, Kook D, et al. Modification of amniotic membrane as a depot carrier for bevacizumab - an in-vitro model for a slow release mechanism [J]. Curr Eye Res, 2013,38(4):445-450.
|
| 23 |
Hazarika M, Prajna NV, Senthilkumari S. Drug reservoir function of voriconazole impregnated human amniotic membrane: An in vitro study[J]. Indian J Ophthalmol, 2021,69(5):1068-1072.
|
| 24 |
Utheim TP, Aass Utheim Ø, Salvanos P, et al. Concise review: Altered versus unaltered amniotic membrane as a substrate for limbal epithelial cells [J]. Stem Cells Transl Med, 2018,7(5):415-427.
|
| 25 |
Zhang T, Yam GH, Riau AK, et al. The effect of amniotic membrane de-epithelialization method on its biological properties and ability to promote limbal epithelial cell culture [J]. Invest Ophthalmol Vis Sci, 2013,54(4):3072-3081.
|
| 26 |
Liu H, Zhou Z, Lin H, et al. Synthetic nanofiber-reinforced amniotic membrane via interfacial bonding [J]. ACS Appl Mater Interfaces, 2018,10(17):14559-14569.
|
| 27 |
Zhao J, Fan T, Ma X, et al. Construction of a high cell density human corneal endothelial equivalent and its transplantation in primate models [J]. Xenotransplantation, 2019, 26(4):e12514.
|
| 28 |
Monteiro BG, Loureiro RR, Cristovam PC, et al. Amniotic membrane as a biological scaffold for dental pulp stem cell transplantation in ocular surface reconstruction [J]. Arq Bras Oftalmol, 2019,82(1):32-37.
|
| 29 |
López S, Hoz L, Tenorio EP, et al. Can human oral mucosa stem cells differentiate to corneal epithelia?[J]. Int J Mol Sci, 2021, 22(11):5976.
|
| 30 |
Nosrati H, Alizadeh Z, Nosrati A, et al. Stem cell-based therapeutic strategies for corneal epithelium regeneration[J]. Tissue Cell, 2021, 68:101470.
|
| 31 |
Wang M, Li Y, Wang H, et al. Corneal regeneration strategies: From stem cell therapy to tissue engineered stem cell scaffolds [J]. Biomed pharmacother, 2023, 165:115206.
|
| 32 |
Guo Q, Hao J, Yang Q, et al. A comparison of the effectiveness between amniotic membrane homogenate and transplanted amniotic membrane in healing corneal damage in a rabbit model [J]. Acta Ophthalmol, 2011, 89(4):e315-319.
|
| 33 |
Tighe S, Moein HR, Chua L, et al. Topical cryopreserved amniotic membrane and umbilical cord eye drops promote re-epithelialization in a murine corneal abrasion model [J]. Invest Ophthalmol Vis Sci, 2017, 58(3):1586-1593.
|
| 34 |
Wu MF, Stachon T, Langenbucher A, et al. Effect of amniotic membrane suspension (ams) and amniotic membrane homogenate (amh) on human corneal epithelial cell viability, migration and proliferation in vitro[J]. Curr Eye Res, 2017, 42(3):351-357.
|
| 35 |
Choi JA, Jin HJ, Jung S, et al. Effects of amniotic membrane suspension in human corneal wound healing in vitro[J]. Mol Vis, 2009, 15:2230-2238.
|
| 36 |
Yam GH, Yusoff NZ, Kadaba A, et al. Ex vivo propagation of human corneal stromal "activated keratocytes" for tissue engineering [J]. Cell Transplant, 2015, 24(9):1845-1861.
|
| 37 |
Zhu YT, Li F, Zhang Y, et al. Hc-ha/ptx3 purified from human amniotic membrane reverts human corneal fibroblasts and myofibroblasts to keratocytes by activating bmp signaling [J]. Invest Ophthalmol Vis Sci, 2020,61(5):62.
|
| 38 |
Yao M, Chen J, Yang XX, et al. Differentiation of human amniotic epithelial cells into corneal epithelial-like cells in vitro [J]. Int J Ophthalmol, 2013, 6(5):564-572.
|
| 39 |
Luo H, Lu Y, Wu T, et al. Construction of tissue-engineered cornea composed of amniotic epithelial cells and acellular porcine cornea for treating corneal alkali burn[J]. Biomaterials, 2013, 34(28):6748-6759.
|
| 40 |
Zhou Q, Liu XY, Ruan YX, et al. Construction of corneal epithelium with human amniotic epithelial cells and repair of limbal deficiency in rabbit models[J]. Hum Cell, 2015, 28(1):22-36.
|
| 41 |
Sha X, Liu Z, Song L, et al. Human amniotic epithelial cell niche enhances the functional properties of human corneal endothelial cells via inhibiting p53-survivin-mitochondria axis[J]. Exp Eye Res, 2013,116:36-46.
|
| 42 |
Kamiya K, Wang M, Uchida S, et al. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea[J]. Exp Eye Res, 2005,80(5):671-679.
|
| 43 |
Fathi I, Miki T. Human amniotic epithelial cells secretome: components, bioactivity, and challenges[J]. FrontMed, 2022,8:763141.
|
| 44 |
Hu S, Wang Z, Jin C, et al. Human amniotic epithelial cell-derived extracellular vesicles provide an extracellular matrix-based microenvironment for corneal injury repair[J]. J Tissue Eng, 2022, 13:20417314221122123.
|
| 45 |
Clare G, Bunce C, Tuft S. Amniotic membrane transplantation for acute ocular burns[J]. Cochrane Database Syst Rev, 2022, 9(9):CD009379.
|
| 46 |
Liu J, Li L, Li X. Effectiveness of cryopreserved amniotic membrane transplantation in corneal ulceration: a Meta-analysis[J]. Cornea, 2019, 38(4):454-462.
|
| 47 |
Siu GDJ, Kam KW, Young AL. Amniotic membrane transplant for bullous keratopathy: Confocal microscopy & anterior segment optical coherence tomography[J]. Semin Ophthalmol, 2019, 34(3):163-167.
|
| 48 |
de Farias CC, Allemann N, Gomes Já. Randomized trial comparing amniotic membrane transplantation with lamellar corneal graft for the treatment of corneal thinning[J]. Cornea, 2016, 35(4):438-444.
|
| 49 |
Konomi K, Satake Y, Shimmura S, et al. Long-term results of amniotic membrane transplantation for partial limbal deficiency[J]. Cornea, 2013, 32(8):1110-1115.
|
| 50 |
Campbell JDM, Ahmad S, Agrawal A, et al. Allogeneic ex vivo expanded corneal epithelial stem cell transplantation: a randomized controlled clinical trial[J]. Stem Cells Transl Med, 2019, 8(4):323-331.
|
| 51 |
Dua HS, Miri A, Elalfy MS, et al. Amnion-assisted conjunctival epithelial redirection in limbal stem cell grafting[J]. Br J Ophthalmol, 2017, 101(7):913-919.
|
| 52 |
Gopakumar V, Agarwal S, Srinivasan B, et al. Clinical outcome of autologous cultivated oral mucosal epithelial transplantation in ocular surface reconstruction[J]. Cornea, 2019, 38(10):1273-1279.
|
| 53 |
Baradaran-Rafii A, Asl NS, Ebrahimi M, et al. The role of amniotic membrane extract eye drop (ameed) in in vivo cultivation of limbal stem cells[J]. Ocul Surf, 2018, 16(1):146-153.
|
| 54 |
Parmar DN, Alizadeh H, Awwad ST, et al. Ocular surface restoration using non-surgical transplantation of tissue-cultured human amniotic epithelial cells[J]. Am J Ophthalmol, 2006, 141(2):299-307.
|
| 55 |
Hori J, Kunishige T, Nakano Y. Immune checkpoints contribute corneal immune privilege: implications for dry eye associated with checkpoint inhibitors[J]. Int J Mol Sci, 2020, 21(11):3962.
|
| 56 |
Hanstock HG, Edwards JP, Walsh NP. Tear lactoferrin and lysozyme as clinically relevant biomarkers of mucosal immune competence[J]. Front Immunol, 2019, 10:1178.
|
| 57 |
Kumar A, Yun H, Funderburgh ML, et al. Regenerative therapy for the cornea[J]. Prog Retin Eye Res, 2022, 87:101011.
|
| 58 |
Zhang H, Jin ZB. A rational consideration of the genomic instability of human-induced pluripotent stem cells for clinical applications[J]. Sci China Life Sci, 2023, 66(9):2198-2200.
|